Global
49 articles
Curaleaf Formally Launches Aurora Cannabis Takeover Bid — US$4.00 per Share and 45% Premium
Curaleaf Holdings has formally launched its take-over bid for all Aurora Cannabis common shares. The offer provides about US$4.00 per share, comprising 0.3463 Curaleaf shares plus US$0.75 in cash, representing a 45% premium to Aurora’s unaffected share price as of August 10. The offer remains open until December 1, subject to regulatory approvals and minimum tender conditions.
2026-08-18
Nepal’s Gandaki Province Seeks to Allow Medical and Industrial Cannabis Cultivation
Gandaki Province Chief Minister Surendraraj Pandey met Prime Minister Balendra Shah to seek federal legal support for opening cannabis cultivation for medical and industrial purposes. The province says it has already enacted a cannabis cultivation law and views regulated commercialization as a potential source of local employment.
2026-08-17
Canada Invests C$24 Million in Its First National Cannabis and Brain Health Research Consortium
The Government of Canada is investing C$24 million to establish the country’s first National Cannabis and Brain Health Research Consortium. The initiative will build a national research base for systematically examining how cannabis use affects brain and mental health, supporting health-research infrastructure and evidence-based policy discussions.
2026-08-13
Canada’s Organigram Posts Record Q3 FY26 Results — C$105.8M Net Revenue and 35% International Mix
Canada’s Organigram Global reported record fiscal Q3 2026 net revenue of C$105.8 million, up 49% year over year. With the contribution of its Sanity Group acquisition, international revenue rose to 35% of the total, highlighting the company’s expansion into overseas markets including Europe.
2026-08-12
Square Tells Merchants to Halt Hemp and CBD Sales, Citing Impending Federal Restrictions
Payments and POS provider Square has told merchants it will no longer allow CBD and hemp product sales on its platform, citing uncertainty around impending federal hemp-product restrictions. The potential loss of payment infrastructure could directly affect sales channels for smaller hemp businesses, heightening industry concerns.
2026-08-10
Federal report: Daily cannabis use in the U.S. surpasses daily drinking and smoking — 21.4 million
A new federal report from the Substance Abuse and Mental Health Services Administration (SAMHSA) finds that the number of Americans who use cannabis daily or nearly daily has exceeded those who drink alcohol daily or smoke cigarettes daily. As of 2025, about 21.4 million people reported using cannabis on 20 or more of the past 30 days, surpassing roughly 19.9 million daily cigarette smokers. The findings are notable federal empirical evidence that cannabis is emerging as a primary substitute for alcohol and tobacco.
2026-07-29
Health Canada Revises Guidance on Cannabis Imports, Odour Mitigation and Hemp Policy
Canadian authorities have revised guidance covering cannabis imports, odour mitigation, and hemp policy. The changes are part of ongoing regulatory updates to Canada’s cannabis framework since legalization, and the hemp policy revisions are drawing attention alongside contemporaneous U.S. debates on hemp regulation.
2026-07-29
Vireo Growth Acquires Planet 13 in All‑Stock Merger — Becomes One of the Largest MSOs with ~265 Stores across 15 States
Vireo Growth has acquired Planet 13 Holdings through an all‑stock merger. The deal adds Planet 13’s Las Vegas flagship superstore and on‑site consumption lounge, 33 Florida retail locations plus two cultivation and production facilities, and one Illinois store — 36 retail outlets in total. Upon closing, Vireo is expected to operate roughly 265 stores across 15 states, making it one of the largest multi‑state operators (MSOs) in the U.S. cannabis industry.
2026-07-28
Pete Buttigieg: 'Medical Cannabis Has Clearly Brought Change for Veterans and Their Families' — Mentioned as a 2028 Presidential Candidate
Former Transportation Secretary and 2028 presidential contender Pete Buttigieg said that "medical cannabis has clearly brought change for those who served in the military and their extended families." He added that "a majority of Americans recognize that people should have access to this," clearly signaling his support for medical cannabis.
2026-07-27
U.S. Cannabis Sales Fall Year‑over‑Year for First Time — $32.0B (2024) → $29.94B (2025); Cause: Price Compression
U.S. cannabis sales declined year‑over‑year for the first time on record, dropping from $32.0 billion in 2024 to $29.94 billion in 2025. The reduction stems not from weaker demand but from price compression: consumers are buying larger quantities while paying less. The trend reflects a maturing market and signals structural profitability challenges for the industry as prices continue to fall.
2026-07-27
Himachal Pradesh Officially Adopts Regulations Permitting Cannabis Cultivation for Medical and Scientific Purposes — India’s Third State
Himachal Pradesh authorities have officially adopted regulations permitting cultivation of cannabis for medical and scientific purposes. Following cabinet approval in June and formal adoption of the rules in July, the state has become the third in India to allow legal cannabis cultivation. Located in the Himalayan region, Himachal Pradesh has a long tradition of hemp cultivation; the new regulations will enable farmers to lawfully cultivate a high‑value crop. The move reflects growing momentum for state‑level cannabis reform across India, the world’s largest democracy.
2026-07-27
South Korea Puts $21 Million Behind Minor Cannabinoids for Medical Hemp Products
South Korea is investing 29.6 billion won (about $21 million) to move its pioneering industrial hemp program into a new commercialization phase, signaling that medical applications remain the government's top priority for the crop. The four-year project will expand the Andong Industrial Hemp Special Zone in North Gyeongsang Province, aiming to commercialize minor cannabinoids such as CBG, CBC and CBN. Participating companies include Neoken Bio and HLB Life Science R&D, working alongside KIST to build a full pharmaceutical value chain from cultivation to finished medicines.
2026-07-23